Literature DB >> 803234

Inhibition of experimental autoimmune renal tubulointerstitial disease in guinea pigs by depletion of complement with cobra venom factor.

U H Rudofsky, R W Steblay, B Pollara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803234     DOI: 10.1016/0090-1229(75)90027-6

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  7 in total

Review 1.  Immunologically mediated lesions of kidney tubules and interstitium in laboratory animals and in man.

Authors:  J R Brentjens; B Noble; G A Andres
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Immunological, structural and functional relationships between an anti-complementary protein from Crotalus atrox venom, cobra venom factor and human C3.

Authors:  J O Minta; D Man
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

3.  Animal model of human disease: anti-tubular-basement-membrane-antibody tubulointerstitial nephritis.

Authors:  R W Steblay
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

4.  Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis.

Authors:  V A Lennon; M E Seybold; J M Lindstrom; C Cochrane; R Ulevitch
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

5.  Structural observations on epithelioid and giant cells in experimental autoimmune tubulointerstitial nephritis in guinea pigs.

Authors:  G A Andres; C Szymanski; B Albini; J Brentjens; M Milgrom; B Noble; E Ossi; R Steblay
Journal:  Am J Pathol       Date:  1979-07       Impact factor: 4.307

6.  Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea-pigs. III. The role of adjuvants in the induction of disease.

Authors:  U H Rudofsky
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

7.  Acquired resistance to ticks. III. Cobra venom factor and the resistance response.

Authors:  S K Wikel; J R Allen
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.